FDA food facility registration renewal runs October 1 – December 31, 2026. Registrations not renewed by the deadline expire on January 1. Renew now →

+1 (630) 270-2921 info@fdahelp.us

FDA Import Alert Red List: What It Means for Your Business and How LMG Can Help You Get Removed

Is your company or product listed on the FDA Import Alert Red List? Are your shipments facing Detention Without Physical Examination (DWPE)?

For companies importing FDA-regulated products into the United States, understanding FDA Import Alerts is essential. Import Alerts are one of the FDA’s primary enforcement tools for identifying products that may violate U.S. regulations and ensuring potentially non-compliant products do not enter the marketplace. According to the FDA’s Industry FAQs for Import Alerts, Import Alerts help guide import screening and enforcement activities, particularly through a process known as Detention Without Physical Examination (DWPE).

1. What Is an FDA Import Alert?

The U.S. Food and Drug Administration (FDA) issues Import Alerts to help identify products, manufacturers, or countries associated with potential violations of U.S. FDA regulations.

One of the main purposes of an Import Alert is to prevent potentially non-compliant products from entering the U.S. market.

Depending on the applicable Import Alert, shipments may be subject to Detention Without Physical Examination (DWPE).

Under DWPE, FDA may detain applicable shipments at the U.S. port of entry without physically examining the products.

2. Understanding FDA’s Red, Yellow, and Green Lists

The FDA uses three types of lists within certain Import Alerts.

RED LIST – Subject to DWPE

Firms, products, and/or countries that meet the criteria for Detention Without Physical Examination under the applicable Import Alert. Products from entities on the Red List may be automatically detained when entering the United States.

YELLOW LIST – Intensified Surveillance

Firms, products, and/or countries are subject to increased surveillance. This may include situations where GMP concerns have been addressed but still require examination or testing.

GREEN LIST – Exempt from DWPE

Firms, products, and/or countries that have met the applicable criteria for exemption from Detention Without Physical Examination. Being included on the Green List generally means that covered shipments are exempt from automatic detention under that particular Import Alert. It does not mean that the products are exempt from all other FDA requirements or inspections.

Understanding the difference is important because each listing has different regulatory implications.

3. Does Every FDA Detention Mean Your Company Is on the Red List?

No!

According to FDA not every shipment detention is related to an Import Alert violation.

If your shipment has been detained, the first thing to do is review the Notice of FDA Action. This notice explains why the FDA has detained the shipment and what regulatory issue needs to be addressed.

Before importing products into the United States, importers should also search the FDA Import Alert database using multiple criteria, including:

  • Manufacturer name
  • Product name
  • Country of origin

This helps identify potential Import Alert restrictions before shipment.

4. Can a Company Be Removed from the FDA Red List?

This is probably the most important question for companies facing an Import Alert.

Yes! Companies may submit a petition requesting removal from the applicable Import Alert Red List.

However, simply submitting a petition does not guarantee removal.

The FDA evaluates the totality of the evidence presented to determine whether the conditions that resulted in DWPE have been resolved and whether future shipments are expected to be safe and compliant.

For Red List removal, FDA identifies four important areas of supporting evidence:

1. Investigation – Root Cause Analysis (How Did the Problem Occur)

The company should investigate and explain the underlying reason for the violation.

2. Corrective Actions – What Was Done to Fix the Problem?

The company should demonstrate the corrective measures implemented to address the identified violation.

3. Preventive Measures – How Will You Avoid the Same Problem in the Future?

The company should explain the preventive controls and procedures established to prevent similar violations in the future.

4. Supporting Evidence – How Can Compliance Be Demonstrated?

The company should provide relevant evidence demonstrating the effectiveness of its corrective and preventive measures.

Depending on the Import Alert and the nature of the violation, supporting evidence may include:

  • Five consecutive clean commercial shipments, where applicable.
  • Third-party audit reports.
  • Laboratory analysis reports.
  • Manufacturing and quality-control records.
  • Corrective and preventive action documentation.

5. Can a Detained Shipment Be Released Separately From Red List Removal?

Yes, these are two different regulatory processes.

  • When a shipment is detained under DWPE, the importer or consignee may submit testimony and supporting evidence to demonstrate that the product does not have the violation identified in the Import Alert.

The applicable Import Alert’s Guidance section explains the requirements for attempting to secure the release of an individual shipment.

  • However, certain Import Alerts involve violations that require corrective action and removal from DWPE before shipments can be released.

Therefore, obtaining release of an individual shipment does not necessarily mean that the company has been removed from the Red List.

In other words, shipment release and Red List removal are two different regulatory matters. A company may still face detention of future shipments until its listing status is resolved or an applicable exemption is obtained.

6. How Can Liberty Management Group Ltd. (LMG) Help?

Navigating an FDA Import Alert and preparing a removal petition requires a clear understanding of the applicable regulatory requirements and supporting evidence.

This is where LMG can help.

At Liberty Management Group Ltd., we assist companies in understanding their Import Alert status, identifying compliance issues, preparing supporting documentation, and developing a strategy for requesting removal from the applicable Red List.

Our assistance includes:

✔ FDA Import Alert Assessment

Reviewing the applicable Import Alert, identifying the reasons for listing, and understanding the specific removal criteria.

✔ Root Cause Analysis

Assisting in identifying and documenting the underlying reasons for the violation, whether labeling, product composition, microbiological contamination, pesticide residues, heavy metals, GMP deficiencies, or registration non-compliance.

✔ Laboratory Testing Guidance & Coordination

Where laboratory testing is required, we help identify the relevant testing parameters based on the Import Alert and the nature of the violation. We also guide companies in identifying and selecting suitable third-party private laboratories which are FDA-recognized or appropriately accredited laboratories.

✔ Corrective and Preventive Action (CAPA)

We assist in preparing corrective and preventive action documentation that explains how the identified problem has been addressed and what measures have been introduced to prevent recurrence.

✔ Supporting Documentation Review

LMG carefully reviews the complete documentation package to verify that all required documents and supporting evidence have been provided, are properly prepared, and address the applicable FDA Import Alert requirements. We check for missing information, incomplete records, and any additional documentation that may be needed before submitting the removal petition.

✔ FDA Red List Removal Petition Preparation

Assisting in preparing a comprehensive petition addressing the applicable Import Alert requirements, corrective actions, preventive measures, and supporting evidence.

✔ FDA Regulatory Correspondence and Follow-Up

Assisting with regulatory communication and responses to additional information requests relating to the petition.

9. Why Choose LMG?

At Liberty Management Group Ltd., we understand the regulatory challenges faced by international companies exporting products to the United States.

Our experience in U.S. FDA regulatory consulting enables us to assist businesses with regulatory assessments, documentation preparation, and compliance strategies across multiple FDA-regulated industries.

We support companies dealing with:

  • FDA Food Import Alerts
  • Dietary Supplement Import Alerts
  • FDA Drug Import Alerts
  • Cosmetics Regulatory Compliance
  • Medical Device Regulatory Compliance

Whether you need help understanding an Import Alert, reviewing compliance gaps, coordinating laboratory testing, or preparing a Red List removal petition, LMG can guide you through the process.

An FDA Import Alert does not necessarily mean the end of your U.S. export opportunities.

Taking appropriate corrective action and presenting convincing supporting evidence can help your company work toward removal from the applicable Import Alert.

Let LMG assist you in taking the next step toward FDA compliance and restoring your access to the U.S. market.

Contact Liberty Management Group Ltd. (LMG) for professional assistance with FDA Import Alert assessment and Red List removal petition preparation.